Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

Oncogene

Volumn 23, Issue 37, 2004, Pages 6261-6271

  Nakata, Susumu ^a   Yoshida, Tatsushi ^a   Horinaka, Mano ^a,b   Shiraishi, Takumi ^a   Wakada, Miki ^a   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bid; Caspases; Death receptor 5; Histone deacetylase inhibitors; TRAIL

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BUTYRIC ACID; CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; CHIMERIC PROTEIN; DEATH RECEPTOR 5; HISTONE DEACETYLASE INHIBITOR; LUCIFERASE; RIBONUCLEASE; TRICHOSTATIN A; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VORINOSTAT; APOPTOSIS REGULATORY PROTEIN; BID PROTEIN, HUMAN; CARRIER PROTEIN; CASPASE; ENZYME INHIBITOR; HISTONE DEACETYLASE; MEMBRANE PROTEIN; PROTEIN BID; TNFRSF10B PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN HL 60; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SENSITIZATION; UPREGULATION; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; HYDROLYSIS; METABOLISM; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROLYSIS; MEMBRANE GLYCOPROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 4344666663     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207830     Document Type: Article

References (59)

1. Ashkenazi A and Dixit VM. (1998). Science, 281, 1305-1308.
2. Ashkenazi A and Dixit VM. (1999). Curr. Opin. Cell Biol., 11, 255-260.
3. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
4. Davie JR. (1998). Curr. Opin. Genet. Dev., 8, 173-178.
5. Gibson SB, Oyer R, Spalding AC, Andersen SM and Johnson GL. (2000). Mol. Cell. Biol., 20, 205-212.
6. Gong B and Almasan A. (2000). Cancer Res., 60, 5754-5760.
7. Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Boiani N, Lynch DH, Smith CA, Goodwin RG and Kubin MZ. (1999). J. Immunol., 162, 2597-2605.
8. He Q, Lee DI, Rong R, Yu M, Luo X, Klein M, El-Deiry WS, Huang Y, Hussain A and Sheikh MS. (2002a). Oncogene, 21, 2623-2633.
9. He Q, Luo X, Huang Y and Sheikh MS. (2002b). Oncogene, 21, 6032-6040.
10. Hirose T, Sowa Y, Takahashi S, Saito S, Yasuda C, Shindo N, Furuichi K and Sakai T. (2003). Oncogene, 22, 7762-7773.
11. Hitomi T, Matsuzaki Y, Yokota T, Takaoka Y and Sakai T. (2003). FEBS Lett., 554, 347-350.
12. Huang L, Sowa Y, Sakai T and Pardee AB. (2000). Oncogene, 19, 5712-5719.
13. Huang Y, He Q, Hillman MJ, Rong R and Sheikh MS. (2001). Cancer Res., 61, 6918-6924.
14. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP and Zhou T. (2001). Nat. Med., 7, 954-960.
15. Inoue H, Shiraki K, Ohmori S, Sakai T, Deguchi M, Yamanaka T, Okano H and Nakano T. (2002). Int. J. Mol. Med., 9, 521-525.
16. Jang YJ, Park KS, Chung HY and Kim HI. (2003). Cancer Lett., 194, 107-117.
17. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC. (2000). Nat. Med., 6, 564-567.
18. Keane MM, Ettenberg SA, Nau MM, Russell EK and Lipkowitz S. (1999). Cancer Res., 59, 734-741.
19. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D and Ashkenazi A. (2001). J. Biol. Chem., 276, 46639-46646.
20. Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG and de Jong S. (2003). J. Pathol., 200, 327-335.
21. Kouzarides T. (1999). Curr. Opin. Genet. Dev., 9, 40-48.
22. Kramer OH, Gottlicher M and Heinzel T. (2001). Trends Endocrinol. Metab., 12, 294-300.
23. Kuang AA, Diehl GE, Zhang J and Winoto A. (2000). J. Biol. Chem., 275, 25065-25068.
24. La Vallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ and Pribluda VS. (2003). Cancer Res., 63, 468-475.
25. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D and Ashkenazi A. (2001). Nat. Med., 7, 383-385.
26. LeBlanc HN and Ashkenazi A. (2003). Cell Death Differ., 10, 66-75.
27. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM and Alnemri ES. (1997). J. Biol. Chem., 272, 25417-25420.
28. Mariani SM, Matiba B, Armandola EA and Krammer PH. (1997). J. Cell Biol., 137, 221-229.
29. Marks PA, Richon VM and Rifkind RA. (2000). J. Natl. Cancer Inst., 92, 1210-1216.
30. Meng RD and El-Deiry WS. (2001). Exp. Cell Res., 262, 154-169.
31. Mitsiades N, Poulaki V, Mitsiades C and Tsokos M. (2001). Cancer Res., 61, 2704-2712.
32. Muhlenbeck F, Haas E, Schwenzer R, Schubert G, Grell M, Smith C, Scheurich P and Wajant H. (1998). J. Biol. Chem., 273, 33091-33098.
33. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK and Huang HJ. (2000). Cancer Res., 60, 847-853.
34. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H and Sakai T. (1997). J. Biol. Chem., 272, 22199-22206.
35. Neuzil J, Swettenham E and Gellert N. (2004). Biochem. Biophys. Res. Commun., 314, 186-191.
36. Oh SC, Nam SY, Kwon HC, Kim CM, Seo JS, Seong RH, Jang YJ, Chung YH and Chung HY. (2001). Mol. Cell, 11, 192-197.
37. Ohtsuka T, Buchsbaum D, Oliver P, Makhija S, Kimberly R and Zhou T. (2003). Oncogene, 22, 2034-2044.
38. Pan G, Ni J, Wei YF, Yu G, Gentz R and Dixit VM. (1997). Science, 277, 815-818.
39. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A. (1996). J. Biol. Chem., 271, 12687-12690.
40. Rosato RR, Almenara JA, Dai Y and Grant S. (2003). Mol. Cancer Ther., 2, 1273-1284.
41. Screaton GR, Mongkolsapaya J, Xu XN, Cowper AE, McMichael AJ and Bell JI. (1997). Curr. Biol., 7, 693-696.
42. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace Jr AJ and El-Deiry WS. (1998). Cancer Res., 58, 1593-1598.
43. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P and Ashkenazi A. (1997). Science, 277, 818-821.
44. Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N and Eguchi K. (2003). Oncogene, 22, 1653-1662.
45. Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H and Sakai T. (1997). Biochem. Biophys. Res. Commun., 241, 142-150.
46. Strahl BD and Allis CD. (2000). Nature, 403, 41-45.
47. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK and Lotan R. (1999). Oncogene, 18, 2357-2365.
48. Takimoto R and El-Deiry WS. (2000). Oncogene, 19, 1735-1743.
49. Tang X, Sun YJ, Half E, Kuo MT and Sinicrope F. (2002). Cancer Res., 62, 4903-4908.
50. Walczak H, Bouchon A, Stahl H and Krammer PH. (2000). Cancer Res., 60, 3051-3057.
51. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG and Rauch CT. (1997). EMBO J., 16, 5386-5397.
52. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
53. Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E and Bhalla K. (2000). Blood, 96, 3900-3906.
54. Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and El-Deiry WS. (1997). Nat. Genet., 17, 141-143.
55. Wu GS, Burns TF, McDonald III ER, Meng RD, Kao G, Muschel R, Yen T and El-Deiry WS. (1999). Oncogene, 18, 6411-6418.
56. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV and Mak TW. (1998). Science, 279, 1954-1958.
57. Yoshida M and Beppu T. (1988). Exp. Cell Res., 177, 122-131.
58. Yoshida T, Maeda A, Tani N and Sakai T. (2001). FEBS Lett., 507, 381-385.
59. Zhang XD, Gillespie SK, Borrow JM and Hersey P. (2003). Biochem. Pharmacol., 66, 1537-1545.